RESEARCH ON THE SAFETY AND ACTIVITY OF MELOXICAM TABLETS FOR CHILDREN
Open Access
- 1 January 2025
- journal article
- Published by Non-state educational institution "Kazakh-Russian Medical University" in Actual Problems of Theoretical and Clinical Medicine
- Vol. 50 (4)
Abstract
The development of safe and effective anti-inflammatory dosage forms for children is one of the most important areas of modern pharmaceutical science. Among nonsteroidal anti-inflammatory drugs, meloxicam is among the most commonly used substances in clinical practice. Objective. To study the preclinical toxicity and anti-inflammatory activity of meloxicam tablets for children (coated, prolonged effects, special dose). Methods and materials: acute toxicity in animals was determined, as well as an assessment of specific pharmacological activity in models of histamine-induced and carrageenan aseptic inflammation. Study results: The study showed that Meloxicam tablets for children are non-toxic and have greater anti-inflammatory activity than the comparison drug. The study on the specific activity of Meloxicam 3.75 mg tablets for children + cyanocobalamin 0.002 mg demonstrated their high anti-inflammatory activity in experimental aseptic inflammation models. This indicates an increased anti-inflammatory effect of meloxicam when combined with cyanocobalamin. Conclusion: the results showed that the anti–inflammatory activity of the studied drug, meloxicam children’s tablets, is higher than that of the comparative drug meloxicam.Keywords
This publication has 6 references indexed in Scilit:
- Effect of Combined Diclofenac and B Vitamins (Thiamine, Pyridoxine, and Cyanocobalamin) for Low Back Pain Management: Systematic Review and Meta-analysisPain Medicine, 2019
- Longitudinal Health Status from Early Disease to Adulthood and Associated Prognostic Factors in Juvenile Idiopathic ArthritisThe Journal of Rheumatology, 2019
- Anti-nociceptive and Anti-inflammatory Effects of Cyanocobalamin (Vitamin B12) Against Acute and Chronic Pain and Inflammation in MiceArzneimittelforschung, 2012
- Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR studyCurrent Medical Research and Opinion, 2009
- Chapter 4 European guidelines for the management of chronic nonspecific low back painEuropean Spine Journal, 2006
- Adjuvant Analgesics in Cancer Pain ManagementThe Oncologist, 2004